About Infinion Biopharma Limited
Data last updated:
Infinion Biopharma Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2018PLC100571. Its GSTIN is 24AAHCG1542M1ZL (Gujarat).
The company has an authorised share capital of ₹17.5 Cr and a paid-up capital of ₹10.59 Cr. It was formerly known as Infinion Biopharma Private Limited and Glia Biopharmaceutical Private Limited. It is led by directors including Dhruv Desai (Managing Director) and Pankaj Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹91.8 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.99 Cr (net margin -216.4%) and EBITDA of -₹1.9 Cr (EBITDA margin -207%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Infinion BioPharma. The company has 5 deals on record (3 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹9.33 Cr; the latest was in May 2022.
For more details, the company can be reached via its website infinionbiopharma.com.
Company details
Name history
Infinion Biopharma has undergone 2 name changes throughout its history. The company was previously known as Infinion Biopharma Private Limited, and Glia Biopharmaceutical Private Limited. The current legal name is Infinion Biopharma Limited.
| Company Name | Status |
|---|---|
| Infinion Biopharma Limited | Current |
| Infinion Biopharma Private Limited | Previous |
| Glia Biopharmaceutical Private Limited | Previous |
CIN history
Infinion Biopharma has one previous CIN (Corporate Identification Number): U51909GJ2018PTC100571. The current CIN is U51909GJ2018PLC100571, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909GJ2018PLC100571 | Current |
| U51909GJ2018PTC100571 | Previous |
Contact details
Infinion Biopharma Limited's registered office is in Ahmedabad, Gujarat. Its website is infinionbiopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address407 Silver Radiance Pakwan Char Rasta Sindhu Bhavan Road B, Odakdev, Ahmedabad, Gujarat, India – 380054
- IndustryLife Sciences, Biotechnology
To see the full contact details of Infinion Biopharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Infinion Biopharma operates one associated brand: Infinion BioPharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Small molecule therapeutics are developed for infections and pain management. | infinionbiopharma.com |
Business activity
The main business activity of Infinion Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Infinion Biopharma Limited, buy the company report.
Financials of Infinion Biopharma Limited
FY 2024 filings availableInfinion Biopharma Limited reported revenue of ₹91.8 Lakh (up 1559% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over three years. EBITDA fell 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.99 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -207% | ||||
| Net Profit Margin | -216.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Infinion Biopharma Limited, buy the company report.
Board of directors of Infinion Biopharma Limited
Infinion Biopharma has 4 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Kumar Singh Also directs: Abcone International Private Limited, Rare Earth Constructions Private Limited, BPJ Edufluence Private Limited and 4 more | Director | 30 Sep 2019 | 7 Years 1 Months | Current |
| Gautam Bali Also directs: Vestify Consultants LLP, Bali Brandedge Consulting LLP, Signedge Leather Private Limited and 5 more | Director | 25 Jul 2018 | 8 Years 3 Months | Current |
| Vishal Harshvardhan Jain Also directs: Amphina Therapeutics Private Limited | Director | 10 Mar 2018 | 8 Years 8 Months | Current |
| Dhruv Desai Also directs: Amphina Therapeutics Private Limited, Posha Organics LLP, Ishwara Enterprise LLP and 1 more | Managing Director | 07 Sep 2025 | 1 Years 2 Months | Current |
Auditor
Infinion Biopharma Limited is audited by DHARMENDRA & KHAJANCHI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHARMENDRA & KHAJANCHI | FY 2023 | 102472W |
Shareholding
The shareholding of Infinion Biopharma Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Infinion Biopharma Limited, buy the company report.
Deals & funding
Infinion Biopharma Limited has 5 deals on record (3 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹9.33 Cr; the latest was in May 2022.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Funding round | ₹10 Lakh | Investors: Sneh Academic Services Private Limited |
| Jun 2020 | Rights issue | ₹2.3 Cr | Investors: Haveli Marble Private Limited , Quality Life Sciences Private Limited, 2 individuals |
| Jan 2020 | Funding round | ₹1.69 Cr | Investors: 4 individuals |
| Jun 2018 | Funding round | ₹7.54 Cr | Investors: Axon Healthcare Investments Limited, Quality Life Sciences Private Limited, 2 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Infinion Biopharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Infinion Biopharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Infinion Biopharma has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Amphina Therapeutics Private Limited | U85100GJ2020PTC112901 | |
| Innovate Lifesciences Private Limited | U85300GJ2020PTC112885 |
To see the full group structure of Infinion Biopharma Limited, buy the company report.
GST
Infinion Biopharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCG1542M1ZL | Gujarat | Active | 31 May 2018 |
To see the full GST registrations and return filing status of Infinion Biopharma Limited, buy the company report.
Recent activity
Infinion Biopharma Limited has 14 board changes on record since 2018: 7 appointments and 7 cessations. The latest: Dhruv Desai was appointed as Managing Director on 07 Sep 2025.
5 earlier events are in the company report.
Frequently asked questions
Infinion Biopharma is an active public limited company based in Ahmedabad, Gujarat, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 January 2018 (8+ years old) and is registered under CIN U51909GJ2018PLC100571.
Infinion Biopharma has 4 current directors:
- Dhruv Desai - Managing Director
- Pankaj Kumar Singh - Director
- Gautam Bali - Director
- Vishal Harshvardhan Jain - Director
The latest financial statements of Infinion Biopharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Infinion Biopharma is 24AAHCG1542M1ZL, registered in Gujarat.
The CIN (Corporate Identification Number) of Infinion Biopharma is U51909GJ2018PLC100571. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Infinion Biopharma was incorporated on 16 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Infinion Biopharma has 5 deals on record (3 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹9.33 Cr; the latest was in May 2022.
Dhruv Desai was appointed as Managing Director on 07 Sep 2025. Shivani Pathak was appointed as Company Secretary on 02 Sep 2024. Jayantilal Nathalal Patel ceased to be Director on 26 Jul 2022. Infinion Biopharma has 14 board changes on record in total.
Infinion Biopharma can be reached through the website infinionbiopharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Infinion Biopharma is at 407 Silver Radiance Pakwan Char Rasta Sindhu Bhavan Road B, Odakdev, Ahmedabad, Gujarat, India – 380054.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
